Stockreport

CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference

CervoMed Inc.  (CRVO) 
PDF Data further support choice of patient population and dosing regimen in CervoMed's planned Phase 3 trial in dementia with Lewy bodies (DLB) DLB is the second most commo [Read more]